Spruce Biosciences (SPRB)
(Delayed Data from NSDQ)
$0.70 USD
+0.01 (2.14%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $0.70 0.00 (-0.17%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | 43.90% |
ABR | 2.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.33 |
Next Year | -1.16 |
EPS (TTM) | -1.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.12M | 1.37M | 4.92M | NA |
# of Estimates | 2 | 2 | 2 | NA |
High Estimate | 1.23M | 1.50M | 4.92M | NA |
Low Estimate | 1.00M | 1.23M | 4.91M | NA |
Year ago Sales | 1.96M | 2.17M | 10.09M | 4.92M |
Year over Year Growth Est. | -43.11% | -37.10% | -51.28% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.31 | -1.33 | -1.16 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.34 | -0.31 | -1.21 | -0.58 |
High Estimate | -0.27 | -0.29 | -1.15 | -0.58 |
Low Estimate | -0.34 | -0.34 | -1.59 | -1.87 |
Year ago EPS | -0.40 | -0.32 | -1.24 | -1.33 |
Year over Year Growth Est. | 20.00% | 3.13% | -7.26% | 12.84% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.31 | -1.33 | -1.16 |
7 Days Ago | -0.32 | -0.31 | -1.33 | -1.16 |
30 Days Ago | -0.32 | -0.31 | -1.33 | -1.16 |
60 Days Ago | -0.37 | -0.36 | -1.50 | -1.72 |
90 Days Ago | -0.37 | -0.36 | -1.50 | -1.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.31 | -1.33 | -1.16 |
Zacks Consensus Estimate | -0.32 | -0.31 | -1.33 | -1.16 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.30 | -0.32 | -0.40 | NA |
Estimate | -0.41 | -0.34 | -0.37 | -0.42 | NA |
Difference | 0.18 | 0.04 | 0.05 | 0.02 | 0.07 |
Surprise | 43.90% | 11.76% | 13.51% | 4.76% | 18.48% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more